NSN 6505-01-204-5298
Part Details | USP NAPROXEN TABLETS
6505-01-204-5298
Alternate Parts: NDC67253062110, NDC67253-0621-10, NDC00781116413, NDC00781-1164-13, 00904559060, NDC00904559060, NDC00904-5590-60, NDC51079079420, NDC51079-0794-20, NDC00004631401, NDC00004-6314-01, 00004631401, NDC18393027353, NDC18393-0273-53, 00903014801, NDC00903014801, NDC00903-0148-01, 6505-01-204-5298, 01-204-5298, 6505012045298, 012045298
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 27, 1985 | 01-204-5298 | 34194 ( NAPROXEN TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-204-5298
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC67253-0621-10 | 373U9 | DAVA PHARMACEUTICALS, INC. |
| NDC00781-1164-13 | 59043 | GENEVA PHARMACEUTICALS INC |
| 00904559060 | 0SYT3 | MAJOR PHARMACEUTICALS INC |
| NDC00904-5590-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC |
| NDC51079-0794-20 | 65751 | MYLAN INSTITUTIONAL INC. |
| NDC00004-6314-01 | 66002 | ROCHE LABORATORIES INC. |
| 00004631401 | 66002 | ROCHE LABORATORIES INC. |
| NDC18393-0273-53 | 26282 | SYNTEX LABORATORIES INC |
| 00903014801 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
| NDC00903-0148-01 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-204-5298
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | STRIP |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB375.000 MILLIGRAMS NAPROXEN |
| FEATURES PROVIDED | UNIT DOSE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | NAPROXEN TABLETS USP 375MG 100S PG |